A new market study, titled Allergic Rhinitis Market Size has been featured on Market Research Future (MRFR).
Allergic Rhinitis Market Research Report 2019: Industry Size, Share, Trends, Growth and Opportunity Assessment, Regional Analysis and Segmentation By Type (Seasonal, Perennial and Non allergic rhinitis), by Treatment (Antihistamines, Decongestants, Eye drops, Nasal sprays and others) and by Test (Skin Test, IgE RAST Test and Complete Blood Count) – Forecast to 2023
Allergic rhinitis is commonly known as hay fever. The diagnosis of the same is done when clear case symptoms like itchiness in eyes, mouth, nose, throat, skin and other parts of the body in noticed. There are various other symptoms aiding the growth of the market, this includes running nose, cough and sore throat, watery eyes, sneezing, problem with smelling, and others. It can be caused due to allergens like animal dander, mould, pollen, and dust.
It was reported that weakened immunity level has majorly contributed to the prevalence of allergy cases across the globe. A thorough report on the global allergic rhinitis market was undertaken by Market Research Future (MRFR). The report predicted the global market to garner a CAGR of 7% during the forecast period 2017 and 2023. Additionally, the market is anticipated to reach a valuation of USD 15 billion by the end of the forecast period.
Competitive Landscape
Various external factors are defining the market’s growth trajectory. This is contingent on the practices and the strategic approaches used and applied by the market players in the global allergic rhinitis market. The emergence of various revolutionary innovations in products and services is one of the biggest factors contributing to the success of the market and influencing the demand of the market. Add to this, the availability of a sound and proficient labor force, coupled with abundant resources, is contributing to the overall development of the allergic rhinitis drugs market The foremost factor driving its growth is the strategies employed by the key players operating in the market.
MRFR profiled several key players in its recently released report through a precisely conducted primary research. The report includes names like Faes, Farma (Spain), Sanofi (France), Cigna (USA), Himalaya (India), Hisamitsu Pharmaceutical Co.in (Japan), J&J (US), Merck (US), Ampio pharmaceutical Inc. (US), Chong kun Dang Pharmaceutical Corp. (South Korea), GSK (UK), Glenmark Pharmaceutical (India), Olain Farm (Lavtvia) and others.
June 2019, ALK-Abelló, an allergy specialist company of Denmark, mentioned the successful completion of the marketing authorization procedure and approval for its all new tree sublingual allergy immunotherapy (SLIT) tablet across 17 European nations.
Intended Audience
Regional Analysis
The global allergic rhinitis market segments into four key regions, namely Europe, North America, the Middle East & Africa, and Asia Pacific.
The North American region hold the dominant share in the global allergic rhinitis market. The regional market is projected to continue its stay at the top of the rankings over the forecast period. The US is a major contributor to the North American Allergic Rhinitis market. The country reportedly holds the highest number of hay fever incidences in the world, which contributes immensely to the growth of regional market.
The second largest allergic rhinitis market in the world is Europe. Europe stands tall in the global landscape as a key region and is anticipated to continue maintaining its standings by growing at a considerable pace over the forecast period.
The Asia Pacific allergic rhinitis regional market is most recently experiencing high growth owing to the increasing awareness therein concerning the disease and its treatment. The growing prevalence of allergic rhinitis in Asia Pacific is primarily due to the increasing population herein. This is expected to drive the market growth of allergic rhinitis in this region. Japan follows the US with the highest incidence of allergic rhinitis.
Market Segmentation
The global allergic rhinitis market has been segmented in terms of treatment, types, and test.
By types, the market segments into seasonal, perennial, and non-allergic rhinitis.
By treatment, the market includes immunotherapy, sublingual immunotherapy (SLIT), antihistamines, eye drops, nasal sprays, decongestants, and home remedies. The antihistamines segment is narrowed down into Allegra, Xyzal, Zyrtec, and Clarinex. While the decongestants segment is branched down into Afrin Nasal Spray, Sudafed, Zyrtec-D, and Sudafed PE.
By test, the market comprises skin tests, igE RAST test, and complete blood count.
Scope of Report
The report for Global Allergic Rhinitis Market by Market Research Future comprises of extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
Get More Information on Allergic Rhinitis Market Research Report -Forecast To 2023 @ https://www.marketresearchfuture.com/reports/allergic-rhinitis-market-1547
Study objectives
Ask for your specific company profile and country level customization on reports.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Edibles.